The one patient who experienced cardiotoxicity had a GDF-15 level of 889 pg/mL; the number was higher than the median level 703.5 pg/mL of those without cardiotoxicity in the cohort without hypertension, hyperlipidemia, or diabetes. Here, GDF15 is linked to hyperlipidemia.